Compare

Vsee Health, Inc. vs Agape ATP Corp vs Omada Health, Inc. vs GeneDx Holdings Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearVsee Health, Inc.
VSEE
Agape ATP Corp
ATPC
Omada Health, Inc.
OMDA
GeneDx Holdings Corp.
WGS
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$14.62M$1.52M$260.21M$427.54M
Revenue growth (YoY)+40.3%+15.2%+53.2%+40.0%
Gross margin50.3%55.0%65.7%69.7%
Operating margin-65.6%-213.7%-4.6%-3.1%
Net margin-100.6%-149.6%-4.9%-4.9%
Net income-$14.71M-$2.28M-$12.78M-$21.02M
EPS (Diluted)-$0.73-$2.85-$0.35-$0.73
Operating cash flow-$3.45M-$2.41M$18.25M$33.28M
Free cash flow-$3.48Mn/a$16.93M$14.26M
Cash & equivalents$5.27M$140.1K$222.04M$105.00M
Total assets$22.41M$24.59M$305.41M$523.71M
Total liabilities$16.96M$2.17M$75.73M$215.53M
Shareholders' equity$5.45M$22.46M$229.68M$308.18M
Return on year-end equity-269.8%-10.2%-5.6%-6.8%
Shares outstanding33.19M1.00M58.43M29.25M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearVsee Health, Inc.Agape ATP CorpOmada Health, Inc.GeneDx Holdings Corp.
Latest$14.62M
Ended 2025-12-31
$1.52M
Ended 2025-12-31
$260.21M
Ended 2025-12-31
$427.54M
Ended 2025-12-31
1 year earlier$10.42M
Ended 2024-12-31
$1.32M
Ended 2024-12-31
$169.80M
Ended 2024-12-31
$305.45M
Ended 2024-12-31
2 years earlier$5.77M
Ended 2023-12-31
$1.43M
Ended 2023-12-31
$122.78M
Ended 2023-12-31
$202.57M
Ended 2023-12-31
3 years earliern/a$1.86M
Ended 2022-12-31
n/a$234.69M
Ended 2022-12-31
4 years earliern/a$1.02M
Ended 2021-12-31
n/a$212.19M
Ended 2021-12-31